These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 16306183)

  • 1. Adeno-associated virus-based gene therapy for inherited disorders.
    Flotte TR
    Pediatr Res; 2005 Dec; 58(6):1143-7. PubMed ID: 16306183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical gene therapy using recombinant adeno-associated virus vectors.
    Mueller C; Flotte TR
    Gene Ther; 2008 Jun; 15(11):858-63. PubMed ID: 18418415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current development of adeno-associated viral vectors.
    Romano G
    Drug News Perspect; 2005 Jun; 18(5):311-6. PubMed ID: 16193103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant adeno-associated virus vectors for cystic fibrosis gene therapy.
    Flotte TR
    Curr Opin Mol Ther; 2001 Oct; 3(5):497-502. PubMed ID: 11699895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AAV-mediated gene therapy for retinal disorders: from mouse to man.
    Buch PK; Bainbridge JW; Ali RR
    Gene Ther; 2008 Jun; 15(11):849-57. PubMed ID: 18418417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant adeno-associated virus (rAAV) vectors for somatic gene therapy: recent advances and potential clinical applications.
    Hallek M; Wendtner CM
    Cytokines Mol Ther; 1996 Jun; 2(2):69-79. PubMed ID: 9384691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adeno-associated virus as a gene therapy vector: vector development, production and clinical applications.
    Grieger JC; Samulski RJ
    Adv Biochem Eng Biotechnol; 2005; 99():119-45. PubMed ID: 16568890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Administration-route and gender-independent long-term therapeutic correction of phenylketonuria (PKU) in a mouse model by recombinant adeno-associated virus 8 pseudotyped vector-mediated gene transfer.
    Ding Z; Georgiev P; Thöny B
    Gene Ther; 2006 Apr; 13(7):587-93. PubMed ID: 16319947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Gene delivery using adeno-associated (AAV) vectors].
    Funato T
    Nihon Rinsho; 1998 Mar; 56(3):701-4. PubMed ID: 9549360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adeno-associated virus mediated gene therapy for retinal degenerative diseases.
    Stieger K; Cronin T; Bennett J; Rolling F
    Methods Mol Biol; 2011; 807():179-218. PubMed ID: 22034031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved cardiac gene transfer by transcriptional and transductional targeting of adeno-associated viral vectors.
    Müller OJ; Leuchs B; Pleger ST; Grimm D; Franz WM; Katus HA; Kleinschmidt JA
    Cardiovasc Res; 2006 Apr; 70(1):70-8. PubMed ID: 16448634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adeno-associated viral vectors for gene transfer and gene therapy.
    Büeler H
    Biol Chem; 1999 Jun; 380(6):613-22. PubMed ID: 10430026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adeno-associated virus (AAV) based gene therapy for eye diseases.
    Wang S; Liu P; Song L; Lu L; Zhang W; Wu Y
    Cell Tissue Bank; 2011 May; 12(2):105-10. PubMed ID: 21344187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The future of epilepsy treatment: focus on adeno-associated virus vector gene therapy.
    McCown TJ
    Drug News Perspect; 2010 Jun; 23(5):281-6. PubMed ID: 20603651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic gene therapy using adeno-associated virus vectors.
    Patijn GA; Kay MA
    Semin Liver Dis; 1999; 19(1):61-9. PubMed ID: 10349684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production and purification of recombinant adeno-associated vectors.
    Wang L; Blouin V; Brument N; Bello-Roufai M; Francois A
    Methods Mol Biol; 2011; 807():361-404. PubMed ID: 22034039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient CFTR expression from AAV vectors packaged with promoters--the second generation.
    Wang D; Fischer H; Zhang L; Fan P; Ding RX; Dong J
    Gene Ther; 1999 Apr; 6(4):667-75. PubMed ID: 10476227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient and long-term intracardiac gene transfer in delta-sarcoglycan-deficiency hamster by adeno-associated virus-2 vectors.
    Li J; Wang D; Qian S; Chen Z; Zhu T; Xiao X
    Gene Ther; 2003 Oct; 10(21):1807-13. PubMed ID: 12960970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AAV serotype-1 mediates early onset of gene expression in mouse hearts and results in better therapeutic effect.
    Su H; Huang Y; Takagawa J; Barcena A; Arakawa-Hoyt J; Ye J; Grossman W; Kan YW
    Gene Ther; 2006 Nov; 13(21):1495-502. PubMed ID: 16775632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Technology evaluation: AAV-CFTR vector, targeted genetics.
    Tebbutt SJ
    Curr Opin Mol Ther; 1999 Aug; 1(4):524-9. PubMed ID: 11713770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.